Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 40 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
根据最新的财务报表(Form-10K),Park Ha Biological Technology Co Ltd 的总资产为 $0,净亏损为 $0
BYAH 的关键财务比率是什么?
Park Ha Biological Technology Co Ltd 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Park Ha Biological Technology Co Ltd 的收入按细分市场或地理位置如何划分?
Park Ha Biological Technology Co Ltd 最大收入来源是 Franchise Fees,在最近的收益报告中收入为 1,510,809。就地区而言, China 是 Park Ha Biological Technology Co Ltd 的主要市场,收入为 2,524,843。
Park Ha Biological Technology Co Ltd 是否盈利?
否,根据最新的财务报表,Park Ha Biological Technology Co Ltd 的净亏损为 $0